# Jubilant DraxImage Inc., dba Jubilant Radiopharma – FDA Inspection, Mar 23, 2026

Source: https://www.keypedia.com/records/fda_inspections/jubilant-draximage-inc-dba-jubilant-radiopharma/30cde839-f0c5-4e2e-8665-b804efa6e542
Source feed: FDA_Inspections

> FDA inspection 1308792 of Jubilant DraxImage Inc., dba Jubilant Radiopharma, March 23, 2026. 2 citations under 21 CFR part 212. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1308792
- Company Name: Jubilant DraxImage Inc., dba Jubilant Radiopharma
- Inspection Date: 2026-03-23
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Orleans District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 984555 - 2016-09-13
- FDA Inspection 827247 - 2013-04-12

## Related Officers

- [Investigator](https://www.keypedia.com/people/pearl-c-ozuruigbo/28ec383e-a602-4764-8d14-20b1049f93d7)
- [Issuing Officer](https://www.keypedia.com/people/tareq-w-haddad/5dcb10ba-950c-4dea-b351-0b129675f6d2)

Company: https://www.keypedia.com/companies/jubilant-draximage-inc-dba-jubilant-radiopharma/e93ebd53-d49f-4ec4-8e7f-e24361a47374

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea